Literature DB >> 7706756

Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?

M Sospedra1, G Obiols, L F Babi, E Tolosa, F Vargas, C Roura-Mir, A Lucas-Martin, G Ercilla, R Pujol-Borrell.   

Abstract

Thyroid follicular cells (thyrocytes) from Graves' disease (GD) patients' thyroid glands express HLA class II molecules "ectopically." This phenomenon has been attributed to induction by locally produced cytokines and may be relevant to disease pathogenesis. We have compared IFN-gamma-mediated induction of HLA class II in thyrocytes from glands affected with GD and a nonautoimmune disease (MNG), to investigate a possible differential regulation of HLA expression between these two pathologies. HLA induction has been measured in primary thyrocyte cultures and control autologous macrophages stimulated or not stimulated with IFN-gamma. Comparison of flow cytometric data using an improved algorithm demonstrated that expression of HLA class II molecules is more readily induced in thyrocytes from GD than from MNG thyroid glands. This higher inducibility was parallel to a faster and stronger induction of HLA class II message in GD thyrocytes but did not correlate with the levels of HLA class II or class I originally expressed by thyrocytes in the tissue or with the degree of lymphocytic infiltration of the gland. There was no association with a particular HLA class II allele or with the presence of IFN-gamma and IL-2 in the tissue, as assessed by reverse transcription-PCR. No differences in the induction of class II were found in macrophages from each group of patients. These results suggest that an intrinsic feature of thyrocytes from GD patients is an up-regulation of HLA class II expression and that this is a characteristic that may facilitate the triggering of autoimmunity to "hyperinducible" thyroid glands.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706756

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers.

Authors:  M P Armengol; M Juan; A Lucas-Martín; M T Fernández-Figueras; D Jaraquemada; T Gallart; R Pujol-Borrell
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Viruses, cytokines, antigens, and autoimmunity.

Authors:  R Gianani; N Sarvetnick
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells.

Authors:  Z Wu; P A Biro; R Mirakian; L Hammond; F Curcio; F S Ambesi-Impiombato; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders.

Authors:  X Ferrer-Francesch; P Caro; L Alcalde; M P Armengol; Y Ashhab; A Lucas-Martín; E M Martínez-Cáceres; M Juan; R Pujol-Borrell
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

5.  Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.

Authors:  N Shimojo; Y Kohno; K Yamaguchi; S Kikuoka; A Hoshioka; H Niimi; A Hirai; Y Tamura; Y Saito; L D Kohn; K Tahara
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.